West Pharmaceutical Services Inc. Common Stock (WST)
Stock · NYSE · Health Care
$337.47as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Support level
$242.41
Industry
Medical/Dental Instruments
About WST
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge c…
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Employees
- 10,800
- Website
- www.westpharma.com
Fundamentals
- 1-day range
- $347.94$355.99
- Market cap
- $24.53B
- P/E (trailing)
- 45.28
- P/E (forward)
- 35.53
- EPS (trailing)
- $7.82
- Dividend yield
- 0.25%
- Beta
- 1.14
- Avg. volume
- 781.8K
- Ex-dividend date
- July 29, 2026
- Dividend pay date
- August 5, 2026
52-week range
$223.83$386
Next earnings: October 22, 2026 · EPS estimate $2.19Before Openconfirmed
How West Pharmaceutical Services Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 17, 2026 · via SEC EDGAR / Finnhub
Forecasts
15 analyst ratings
Buy 88%
Hold 13%
Sell 0%
1-year price forecast
High
$459
+36.0%
Median
$410
+21.5%
Low
$340
+0.7%
West Pharmaceutical Services Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- WSTWest Pharmaceutical Services Inc. Common Stock$337.47▼ 2.49%Market cap $24.53BP/E 45.28$223.83$386
- DXCMDexCom Inc. Common Stock$90.8▲ 1.69%Market cap $31.33BP/E 34.53$54.11$92.59
- RMDResMed Inc. Common Stock$240.24▲ 1.90%Market cap $32.38BP/E 21.47$180.27$284.87
- BAXBaxter International Inc. Common Stock$26.12▲ 0.77%Market cap $13.96BP/E —$15.73$30
- GMEDGlobus Medical Inc. Class A Common Stock$83.06▲ 0.63%Market cap $11.01BP/E 21.55$54.15$101.4
- GKOSGlaukos Corporation Common Stock$179.56▼ 1.29%Market cap $10.09BP/E —$73.16$191.62
- PODDInsulet Corporation Common Stock$145.15▲ 1.21%Market cap $9.65BP/E 27.05$126.4$354.88
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| WST West Pharmaceutical Services Inc. Common Stock | $24.53B | 45.28 | $337.47 | ▼ 2.49% | $223.83$386 |
| DXCM DexCom Inc. Common Stock | $31.33B | 34.53 | $90.8 | ▲ 1.69% | $54.11$92.59 |
| RMD ResMed Inc. Common Stock | $32.38B | 21.47 | $240.24 | ▲ 1.90% | $180.27$284.87 |
| BAX Baxter International Inc. Common Stock | $13.96B | — | $26.12 | ▲ 0.77% | $15.73$30 |
| GMED Globus Medical Inc. Class A Common Stock | $11.01B | 21.55 | $83.06 | ▲ 0.63% | $54.15$101.4 |
| GKOS Glaukos Corporation Common Stock | $10.09B | — | $179.56 | ▼ 1.29% | $73.16$191.62 |
| PODD Insulet Corporation Common Stock | $9.65B | 27.05 | $145.15 | ▲ 1.21% | $126.4$354.88 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- WST Gains 15.3% in Three Months as HVP Growth Strengthens OutlookYahoo · 8/13/2026
- WST Q2 Beat and Raised 2026 Outlook Reinforce the HVP Growth StoryYahoo · 8/13/2026
- Should Investors Buy WST as HVP Growth Meets a Premium Valuation?Yahoo · 8/13/2026
- Here's Why You Should Add BrightSpring Stock to Your Portfolio NowYahoo · 8/12/2026
- NPCE Q2 Earnings Beat Estimates on RNS Growth, '26 Revenue View UpYahoo · 8/12/2026
- West (WST) Stock Looks Overvalued After A 47% One Year RunYahoo · 8/12/2026
- CAH Q4 Earnings Beat on Pharma Strength, Revenues Miss, Stock UpYahoo · 8/11/2026
- RDNT Q2 Earnings & Sales Beat on Advanced Imaging, Guidance RaisedYahoo · 8/11/2026
Insider Activity
Insider Actions →Acquired
8.7K
Disposed
219
- Janet Brutschea Haugen · June 30, 2026 · Grant46 @ $359
- Shane Alden Campbell · May 12, 2026 · Option Exercise474
- Shane Alden Campbell · May 12, 2026 · Option Exercise296
- Shane Alden Campbell · May 12, 2026 · Tax Withholding135 @ $312.07
- Shane Alden Campbell · May 12, 2026 · Tax Withholding84 @ $312.07
- Robert F. Friel · May 4, 2026 · Grant791
- William F. Feehery · May 4, 2026 · Grant791
- Paolo Pucci · May 4, 2026 · Grant791
- Douglas A. Michels · May 4, 2026 · Grant791
- Stephen H. Lockhart · May 4, 2026 · Grant791
- Goldman Myla Lai · May 4, 2026 · Grant791
- Deborah L. Keller · May 4, 2026 · Grant791
- Molly Joseph · May 4, 2026 · Grant791
- Janet Brutschea Haugen · May 4, 2026 · Grant791
- Mark A. Buthman · May 4, 2026 · Grant791
Institutional Ownership
March 31, 2026
- Total shares held
- 65.89M
- Total value held
- $15.32B
- Institutional holders
- 744
Top holders this quarter
- Unknown6.84M
- Unknown4.68M
- Unknown3.29M
- Unknown2.66M
- Unknown2.47M
- Unknown2.34M
- Unknown2.24M
- Unknown1.91M
- Unknown1.46M
- Unknown1.34M
See the full, filterable feed with live charts on the MarketWall dashboard.